From: Physician and patient preferences for dosing options in migraine prevention
Migraine Patients (N = 417) | |
---|---|
Age, years, mean (range) | 45 (18–86) |
Women, % | 78 |
Ethnicity, % | |
White/Caucasian | 88 |
Hispanic/Latino | 8 |
Black/African American | 5 |
Education level, % | |
At least college | 54 |
High school | 9 |
Employment status, % | |
Employed full-time | 57 |
Homemaker | 13 |
Retired | 11 |
Annual household income before taxes ≥$75,000 in 2017, % | 43 |
Insurance, % | |
Private/commercial | 82 |
Medicare Part D | 11 |
ACA | 4 |
VA/TRICARE | 3 |
Residence, % | |
Suburban | 54 |
Rural | 23 |
Urban/city | 23 |
Migraine frequency, n (%) | |
CM (≥15 headache days/month) | 86 (21) |
High-frequency EM (10–14 headache days/month) | 103 (25) |
Moderate-frequency EM (5–9 headache days/month) | 228 (55) |